Accolade, Inc. (ACCD)
After hours:
| Previous Close | 6.06 |
| Open | 6.20 |
| Bid | 5.75 x 3000 |
| Ask | 6.10 x 1200 |
| Day's Range | 5.71 - 6.29 |
| 52 Week Range | 4.61 - 55.47 |
| Volume | |
| Avg. Volume | 1,691,018 |
| Market Cap | 407.318M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Accolade Announces Participation in May Investor Conferences
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Thursday, May 12 at 1pm ET. BofA Securities 2022 Healthcare Conference at the Encore Hotel in Las VegasMonday, May 16 at 9:30am ET. 17th Annual Needham Technology & Media Conference (virtual) About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people a
- GlobeNewswire
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2022
Fiscal fourth quarter 2022 revenue of $93.8 million, a 58% increase compared to fiscal fourth quarter 2021 revenue of $59.2 millionFiscal year 2022 revenue of $310.0 million, an 82% increase compared to fiscal year 2021 revenue of $170.4 million SEATTLE, April 28, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 28, 2022. “Fiscal year 2022 represented a transformational time for Accolade. Our stron
- GlobeNewswire
Accolade to Announce Fiscal Fourth Quarter and Full Year 2022 Financial Results
SEATTLE, April 14, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal fourth quarter and full year 2022 financial results on Thursday, April 28, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-519-1281 fo
